Traders Recap: Biogen Idec, Array Biopharma, Universal Display, Amgen SBWire (press release) The company, on April 4, announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article in The Lancet. SELECT was a Phase 2b study designed to determine the efficacy and safety of ... |
